Hematology Oncology Clinic
P.O.Box: 7108
Damascus, Syria
Phone: +963114442257
Mobile phone: +963992200399
E-mail: mkelta@yahoo.com
MOUHAMMED KELTA, M.D.Date of Birth : July 23,1962
Place of Birth : Damascus –Syria
Citizenship : Syrian
Marital Status : Married, Three children
Summary of Qualifications :American Board of Hematology - 1998
American Board of Hematology Recertification - 2005
American Board of Oncology - 1997
American Board of Oncology Recertification - 2005
American Board of Internal Medicine - 1995
American Board of Internal Medicine Recertification - 2005
Federation Licensing Examination (FLEX) - 1992
Educational Commission for Foreign Medical Graduates (ECFMG) - 1991
Training :Visiting Consultant (June 2004)
Bone Marrow Transplant Unit
Fred Hutshinson Cancer Research Center
Seattle- USA
Fellowship (1994-1997) :Hematology & Medical Oncology Department
University of Illinois Hospitals
Chicago – USA
Residency ( 1992-1994) :Internal Medicine Department
University of Health Sciences Hospitals
Chicago Medical School
Chicago – USA
Internship(1991-1992) :Internal Medicine Department
University of Health Sciences Hospitals
Chicago Medical School
Chicago – USA
Medical School (1980-1986) :Aleppo University, School of Medicine
Basic Medical Sciences (1980-1982)
Clinical Sciences (1982-1986)
Degree: Medical Doctor, Aleppo, Syria
Professional Experience :11/1986-5/1987 General Practitioner in private clinic Damascus, Syria
5/1987-5/1989 Practicing physician at the military hospitals Damascus, Syria
and clinics during the national service
5/1989-11/1989 General Practitioner in private clinic Damascus, Syria
11/1989-1/1990 House physician, Ibn El Naphis Hospital Damascus, Syria
1/1990-6/1991 Student, Stanley H. Kaplan Educational Center Chicago, Illinois, USA
7/1991-6/1997 Internal Medicine and Hematology/Oncology Chicago, Illinois, USA
training
7/1997-9/1998 Attending Hematoloy/Oncology physician, Norfolk, Nebraska, USA
Norfolk Medical Oncology PC
10/1998-12/1999 Locum Tenens, Hematology/Oncology , Chicago, Illinois, USA
Cancer Care Point and Comphealth
2/ 2000-7/ 2001 Hematology/Oncology Consultant Doha, Qatar
Hamad General Hospital
8/ 2001- 12/ 2003 Consultant and Head Section Jeddah, Saudi Arabia
Hematology/ BMT
King Faisal Specialist Hospital and Research
Center
1/2004- 5/2009 Director, Bone Marrow Transplant Program Jeddah, Saudi Arabia
King Faisal Specialist Hospital and Research
Center
10/2006- 9/2007 Acting Chairman, Department of Oncology Jeddah, Saudi Arabia
King Faisal Specialist Hospital and Research
Center
10/2007- 5/2009 Deputy Chairman, Department of Oncology Jeddah, Saudi Arabia
King Faisal Specialist Hospital and Research
Center
6/2009- 12/ 2010 Head Section, Gynecologic Malignancies University of Damascus
then Hematologic Malignancies Damascus, Syria
1/ 2011- 8/2011 Private practice Damascus, Syria
9/ 2011- Current Consultant hematology, Director of Adult BMT program
King Faisal Specialist Hospital and Research
Center Jeddah, Saudi Arabia
Professional Membership :American College of Physicians.
American Society of Oncology.
American Society of Hematology.
American Medical Association.
Licensures :Ministry of Health Registration, Damascus, Syria (1986- now)
Illinois medical license, USA, (July 1991-now)
Wisconsin medical license, USA, (April 1994-now)
South Dakota medical license, USA (March 1997-December 1998)
Nebraska medical license, USA (February 1997-October 1998)
Indiana medical license, USA (November 1998- November 2000)
State of Qatar License
Kingdom of Saudi Arabia License
Internation / National Speaker :1. Lymphoma Profile in Qatari Citizens: A10 year study
Presented at The International Symposium on New Trends in The
Management of Lymphoma, Kuwait, November 2000
2. CML Update, 4th Pan Arab Congress, Doha, Qatar, March 2002
3. Pain Management, King Fahed Hospital, Medina, Saudi Arabia, April 2002
4. Sickle Cell Anemia update, Alnoor Hospita,l Mekkah, Saudi Arabia May 2002
5. First Annual Myeloproliferative disorders symposium, Jeddah, Saudi Arabia, October 2002
6. Multiple Myeloma Transplantation, Hamad General Hospita, Doha, Qatar, January 2003
7. CML Update, 5th Pan Arab Congress, Damascus Syria, October 2003
8. Burkitt Lymphoma and Lymphoblatic Lymphoma, Second Annual Hematology Symposium, Jeddah, Saudi Arabia, Sebtember 2003
9. Writing Scientific Paper, Jeddah, Saudi Arabia, October, 2003
10. CML Update, The Fifth International Symposium on Hematology and Transfusion Medicine, Riyadh, Saudi Arabia, March 2004
11. Board Review Course Jeddah, Saudi Arabia, March 2004
12. Velcade- Update on Multiple Myeloma, Hilton Jeddah, Saudi Arabia, October 2004,
13. Non Hodgkin Lymphoma Update, First Non Hodgkin Lymphoma Workshop Hilton Jeddah, Saudi Arabia, December 2004
14. Bone Marrow Transplantation in Multiple Myeloma.The Fifth Oncology Symposium, Jordan, April 2006
15. Neurologic Complications of Hematologic Disorders, Neurology Symposium, KFSHRC, May 2006
16. Multiple Myeloma Update-2008, Hilton Hotel, Saudi Arabia, February, 2008
Member Organizing Committee
1. 4th Pan Arab Congress, Doha, Qatar, March 2002
2. Myeloproliferative Disorders Symposium, Jeddah, October 2002
3. Second Annual Hematology Symposium September 2003
4. Patient Care Day, Adult Hematology/ BMT Support Group Jan. 24, 2006
5. Institution Review Board (IRB), Hamad General Hospital, Doha, Qatar, 2001
6. Institution Review Board (IRB), King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 2002 - 2005
7. Infection Control Committee, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 2002-2006
8. Transfusion Committee, member since July 2006
.
Chairman Organizing Committee
1. Saudi - BMT 2004 International Conference, April 2004
2. Blood Transfusion Committee, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia July 2004- June 2006
3. Institution Review Board (IRB), King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia 2006- May 2009
4. Drug Utilization/ Antibiotic Utilization Subcommittee, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 2005- 2006
Appreciation Certificates
Timely Completion of medical records, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia 2003
Perfect dictation providing complete documentation, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia 2004
JCIA Accreditation
Participation in initial accreditation and 3 year re-accreditation, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
Leading role in writing the internal policies and procedures (IPP’s) for the Hematology/BMT unit, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
Researches and Publications :■Review focusing on low back pain, published in Syria as a M.D. graduation thesis, 1986
■ Several research protocols for outpatient clinical drug trials in sickle cell disease including the protocol, 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia University of Illinois – USA.
■ Abstract on Anti-Angiogenic Treatment of Metastatic Melanoma, Renal Cell and Bladder Cancer with Thalidomide (F.Fata, M.Kelta, R. Hostetter), Cancer Treatment Centers of America, Goshen, Indiana- USA) proceedings of ASCO, volume 19, 2000, Abstract # 1883A. selected by Qatar Medical Journal, Vol.10/ NO.1/ June 2001
■ Lymphoma Profile in Qartari Citizens: A10 year study, Awidi Abbadi, U. Homsi,
K. Rasul, A. Chong, B. Azadeh, G. Ejekam, A. Haidar, Z. Fawzi, A. Mubarak, A. Al-Hassan, M. Kelta, T. Ismail, M. Abu Laban
Presented in part at the international symposium on new trends in the management of lymphoma, Kuwait, 6-8 November, 2000.
Published in Qatar Medical Journal, Vol.10, Number (1), June 2001
■ Review Article on Primary Mediastinal B-cell lymphoma; A review of Pathology and Management
Koen van Besien, Mouhammed Kelta, Pranay Bahaguna. From the Section of Hematology and Oncology, University of Illinois at Chicago and Department of Medicine, Cook County Hospital, Chicago-Illinois, USA. Published in Journal of
Clinical Oncology (JCO), March 15, 2001, Volume 19, Number 6
■ Review Article on Breast Cancer and Pregnancy, Kelta M., Abbadi A., Sharara H.,
Hostetter R., Helmi I., Hamad General Hospital, Doha, Qatar and Surgical Oncology Unit (Cancer Treatment Centers of America), Indiana, USA, published in Jordan Medical Journal V.35, Number (1), May 2001: 17-23
■ Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer
A. Awidi, U. Homsi, R.I. Kakil, A. Mubarak, A. Hassan, M. Kelta, P. Martinez, S. Sulaiti, A. Al Qady, A. Jamhoury, M. Daniel, C. Charles, A. Ambrose, A.S. El-Aloosy
Published in Eur J Cancer 2001 Nov; 37 (16): 2010-4
■Chemotherapy practice guidelines (77 pages)
M. Kelta, A. Awidi, U. Homsi, R. Kakil, A. Mubarak, A. Hassan,
Published 2001, Hamad General Hospital- Doha , Qatar
■ Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon in first trimester: Report of 3 cases and review of the literature, Mubarak A, Kakil R, Awidi A, Al-Homsi U, Fawzi Z, Kelta M, Al-Hassan A. Published in Am J Hematol 2002 Feb; 69 (2): 115-8
■ Study of HER2/neu status in Qatari women with breast carcinoma
Kakil R, Kelta M, Awidi A, Augustin L, Mubarak A, Al-Homsi U, Al-Hassan A, Al-Alosi A, Bener A. Published in Saudi Med J 2003; Vol.24(8): 447-451
■ Kidney Transplantation From Sickle Cell Trait Donor to Sickle Cell Trait Recipient
Khalil ur Rehman, Abdulla Al-Amoudi, Mouhammed Kelta, Abdulla Awad, Kenneth Bridges, Saeed M G Al-Ghamdi. Publishec in Experimental and Clinical transplantation (2007) 2: 698-700
King Faisal Specialist Hospital and Research Center- Jeddah, Saudi Arabia
Brigham and Women’s Hospital, Boston, MA. USA
■ Acute Myeloid leukemia Post-Allogeneic Peripheral Stem Cell Transplant with
Gastric Chloroma
Jalil Ur Rehman, Mohammad, Shinawi, Muhammad Aslam, Mouhammad Kelta
Annals of Saudi Medicine 31(6) November-December 2011: 658-660